Фоновый узор

Fycompa 8 mg comprimidos recubiertos con pelicula

О препарате

Introduction

Patient Information Leaflet

Fycompa 2mg, 4mg, 6mg, 8mg, 10mg and 12mg Film-Coated Tablets

perampanel

Read this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not give it to others even if they have similar symptoms to you, as it may harm them.
  • If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet.

1.What Fycompa is and what it is used for

2.What you need to know before you start taking Fycompa

3.How to take Fycompa

4.Possible side effects

5. Storage of Fycompa

6.Contents of the pack and additional information

1. What is Fycompa and how is it used

Fycompa contains a medicine called perampanel. It belongs to a group of medicines called antiepileptics. These medicines are used to treat epilepsy, when a person has repeated seizure attacks (convulsive crises). Your doctor has prescribed it for you to reduce the number of seizure attacks you have.

Fycompa is used in combination with other antiepileptics to treat specific forms of epilepsy:

In adults, adolescents (12 years of age and older) and children (4 to 11 years of age)

  • It is used to treat seizure attacks that affect a part of the brain (“partial seizures”).
  • These partial seizures may or may not be followed by a seizure that affects the entire brain (“secondary generalization”).

In adults, adolescents (12 years of age and older) and children (7 to 11 years of age)

  • It is also used to treat seizure attacks that affect the entire brain from the start (“generalized seizures”) and cause convulsions.

2. What you need to know before starting Fycompa

DO NOT TAKE Fycompa:

-if you have ever had a severe skin rash or skin peeling, blisters, and/or mouth sores after taking perampanel.

-if you are allergic to perampanel or any of the other ingredients in this medication (listed in section6).

Warnings and Precautions

Consult your doctor or pharmacist before starting Fycompa if you have liver problems or moderate to severe kidney problems.

You should not take Fycompa if you have severe liver problems or moderate to severe kidney problems.

Before starting this medication, you must inform your doctor if you have a history of alcoholism or drug dependence.

There have been reports of increased liver enzymes in some patients taking Fycompa with other antiepileptic medications.

-Fycompa may make you feel dizzy or drowsy, especially at the beginning of treatment.

-Fycompa may make you more prone to falls, especially if you are an older person; this could be due to your underlying condition.

-Fycompa may make you become aggressive, furious, or violent. It may also cause unusual or extreme changes in your behavior or mood, abnormal thoughts, or loss of contact with reality.

If you, a family member, or a friend notice any of these reactions, consult your doctor or pharmacist.

A reduced number of people taking antiepileptic medications have had thoughts of self-harm or suicide. If, at any time, you have these thoughts, consult your doctor immediately.

Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), and Stevens-Johnson syndrome (SSJ), have been reported associated with perampanel treatment.

  • DRESS typically manifests, although not exclusively, with flu-like symptoms and a rash with elevated body temperature, increased liver enzymes, and eosinophilia in blood tests, as well as lymph node swelling.
  • Stevens-Johnson syndrome (SSJ) may initially appear as red spots with a bull's-eye shape or circular patches, often with blisters in the center, located on the trunk. It may also cause ulcers in the mouth, throat, nose, genitals, and eyes (conjunctivitis and eye redness). These severe skin reactions often come with fever or flu-like symptoms. The rash may progress to extensive skin peeling and life-threatening complications, or be fatal.

If you experience any of the above problems after taking Fycompa (or are unsure), consult your doctor or pharmacist.

Children

Fycompa is not recommended for children under 4years of age. The safety and efficacy in children under 4years of age for partial seizures, or under 7years of age for generalized seizures, have not been established.

Other Medications and Fycompa

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This includes over-the-counter medications and herbal medications. Taking Fycompa with some other medications may cause adverse effects or affect how they work. Do not start or stop taking other medications without consulting your doctor or pharmacist.

-Other antiepileptic medications, such as carbamazepine, oxcarbazepine, and phenytoin, used to treat seizures, may affect Fycompa.Inform your doctorif you are takingorhave takenrecentlythese medications as your dose may need to be adjusted.

-Felbamate (a medication used to treat epilepsy) may also affect Fycompa.Inform your doctorif you are takingorhave takenrecentlythis medication as your dose may need to be adjusted.

  • Midazolam (a medication used to stop acute and prolonged seizures, for sedation, and sleep problems) may be affected by Fycompa. Inform your doctor if you are taking midazolam as your dose may need to be adjusted.

-Other medications, such as rifampicin (a medication used to treat bacterial infections),St. John's Wort(a medication used to treat mild anxiety), and ketoconazole (a medication used to treat fungal infections) may affect Fycompa.Inform your doctorif you are takingorhave takenrecentlythese medications as your dose may need to be adjusted.

-Birth control pills (including oral contraceptives, implants, injections, and patches).

Inform your doctor if you are taking birth control pills. Fycompa may make certain birth control pills, such as levonorgestrel, less effective. You should use other safe and effective birth control methods (such as condoms or an intrauterine device) when taking Fycompa. You should continue to do so for a month after stopping treatment. Consult your doctor about which birth control method is suitable for you.

Fycompa and Alcohol

Talk to your doctor before taking alcohol. Be careful with alcohol consumption and epilepsy medications, including Fycompa.

-Drinking alcohol while taking Fycompa may reduce your alertness and affect your ability to drive or use tools and machines.

-Drinking alcohol while taking Fycompa may also worsen any feelings of anger, confusion, or sadness.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication.Do not stop treatment without consulting your doctor first.

-Fycompa is not recommended during pregnancy.

-You should use a reliable birth control method to prevent pregnancy while receiving Fycompa treatment. You should continue to do so for a month after stopping treatment. Inform your doctor if you are taking birth control pills. Fycompa may make certain birth control pills, such as levonorgestrel, less effective. You should use other safe and effective birth control methods (such as condoms or an intrauterine device) when taking Fycompa. Also, you should do so for a month after stopping treatment. Consult your doctor about which birth control method is suitable for you.

The safety of Fycompa components in breast milk is unknown.

Your doctor will weigh the benefits of Fycompa treatment for the mother against the risks for the baby while breastfeeding.

Driving and Using Machines

Do not drive or use machines until you know how Fycompa affects you.

You should talk to your doctor about the effect of epilepsy on driving and using machines.

-Fycompa may make you feel dizzy or drowsy, especially at the beginning of treatment. If this happens, do not drive or use tools or machines.

-Drinking alcoholwhile taking Fycompamay make these effects worse.

Fycompa contains lactose

Fycompa contains lactose (a type of sugar). If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.

3. How to take Fycompa

Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

How much to take

Adults, adolescents (12 years of age and older) in the treatment of partial seizures and generalized seizures:

The initial recommended dose is 2 mg once a day before bedtime.

-Your doctor may increase this dose in increments of 2 mg up to a maintenance dose between 4 mg and 12 mg, depending on your response.

-If you have mild or moderate liver problems, your dose should not exceed 8 mg per day, and dose increases should be made with an interval of at least 2 weeks.

-Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.

In the following table, the recommended doses for the treatment of partial seizures in children between 4 and 11 years of age and generalized seizures in children between 7 and 11 years of age are shown. For more information, see below the table.

Children who weigh:

More than 30 kg

Between 20 kg and no more than 30 kg

Less than 20 kg

Initial recommended dose

2 mg/day

1 mg/day

1 mg/day

Maintenance recommended dose

4-8 mg/day

4-6 mg/day

2-4 mg/day

Maximum recommended dose

12 mg/day

8 mg/day

6 mg/day

Children (4 to 11 years of age) who weigh 30 kg or more in the treatment of partial seizures:

The initial recommended dose is 2 mg once a day before bedtime.

  • Your doctor may increase this dose in increments of 2 mg up to a maintenance dose between 4 mg and 8 mg, depending on your response. Depending on clinical response and patient tolerability, the dose may be increased to a maximum of 12 mg/day.
  • If you have mild or moderate liver problems, your dose should not exceed 4 mg per day, and dose increases should be made with an interval of at least 2 weeks.
  • Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.

Children (4 to 11 years of age) who weigh 20 kg and less than 30 kg in the treatment of partial seizures:

The initial recommended dose is 1 mg once a day before bedtime.

  • Your doctor may increase this dose in increments of 1 mg up to a maintenance dose between 4 mg and 6 mg, depending on your response. Depending on clinical response and patient tolerability, the dose may be increased to a maximum of 8 mg/day.
  • If you have mild or moderate liver problems, your dose should not exceed 4 mg per day, and dose increases should be made with an interval of at least 2 weeks.
  • Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.

Children (4 to 11 years of age) who weigh less than 20 kg in the treatment of partial seizures:

The initial recommended dose is 1 mg once a day before bedtime.

  • Your doctor may increase this dose in increments of 1 mg up to a maintenance dose between 2 mg and 4 mg, depending on your response. Depending on clinical response and patient tolerability, the dose may be increased to a maximum of 6 mg/day.
  • If you have mild or moderate liver problems, your dose should not exceed 4 mg per day, and dose increases should be made with an interval of at least 2 weeks.
  • Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.

Children (7 to 11 years of age) who weigh 30 kg or more in the treatment of generalized seizures:

The initial recommended dose is 2 mg once a day before bedtime.

  • Your doctor may increase this dose in increments of 2 mg up to a maintenance dose between 4 mg and 8 mg, depending on your response. Depending on clinical response and patient tolerability, the dose may be increased to a maximum of 12 mg/day.
  • If you have mild or moderate liver problems, your dose should not exceed 4 mg per day, and dose increases should be made with an interval of at least 2 weeks.
  • Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.

Children (7 to 11 years of age) who weigh 20 kg and less than 30 kg in the treatment of generalized seizures:

The initial recommended dose is 1 mg once a day before bedtime.

  • Your doctor may increase this dose in increments of 1 mg up to a maintenance dose between 4 mg and 6 mg, depending on your response. Depending on clinical response and patient tolerability, the dose may be increased to a maximum of 8 mg/day.
  • If you have mild or moderate liver problems, your dose should not exceed 4 mg per day, and dose increases should be made with an interval of at least 2 weeks.
  • Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.

Children (7 to 11 years of age) who weigh less than 20 kg in the treatment of generalized seizures:

The initial recommended dose is 1 mg once a day before bedtime.

  • Your doctor may increase this dose in increments of 1 mg up to a maintenance dose between 2 mg and 4 mg, depending on your response. Depending on clinical response and patient tolerability, the dose may be increased to a maximum of 6 mg/day.
  • If you have mild or moderate liver problems, your dose should not exceed 4 mg per day, and dose increases should be made with an interval of at least 2 weeks.
  • Do not take more Fycompa than recommended by your doctor. It may take several weeks to find the right dose of Fycompa for you.

How to take

Swallow the tablet whole with a glass of water. Fycompa can be taken with or without food. Do not chew, crush, or break the tablet. The tablets cannot be split exactly since they do not have a score.

If you take more Fycompa than you should

If you have taken more Fycompa than you should, consult your doctor immediately. You may experience drowsiness, agitation, aggressive behavior, and decreased level of consciousness.

If you forget to take Fycompa

-If you forget to take a tablet, wait until it is time to take the next dose and continue as usual.

-Do not take a double dose to compensate for the missed doses.

-If you have missed less than 7 days of treatment with Fycompa, continue taking the tablet daily as originally indicated by your doctor.

-If you have missed more than 7 days of treatment with Fycompa, consult your doctor immediately.

If you interrupt treatment with Fycompa

Take Fycompa for the recommended time by your doctor. Do not interrupt treatment unless your doctor advises you to. Your doctor may gradually reduce your dose to avoid seizures (convulsions) returning or worsening.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medicines, this medicine may cause side effects, although not everyone will experience them.

A reduced number of people taking antiepileptic medications have had thoughts of self-harm or suicide. If, at any time, you have these thoughts, consult your doctor immediately.

Very common(may affect more than 1 in 10 users):

-Dizziness

-Drowsiness (drowsiness or somnolence)

Common(may affect up to 1 in 10 users):

-Increased or decreased appetite, weight gain

-Feeling of aggression, anger, irritability, anxiety, or confusion

-Difficulty walking or other balance problems (ataxia, gait disorder, balance disorder)

-Slow speech (dysarthria)

-Blurred vision or double vision (diplopia)

-Sensation of spinning (vertigo)

-Nausea (gagging)

-Back pain

-Sensation of extreme fatigue (fatigue)

-Falls

Rare(may affect up to 1 in 100 users):

-Thoughts of self-aggression or ending one's life (suicidal thoughts), attempt to end one's life (suicide attempt)

-Hallucinations (seeing, hearing, or feeling things that do not exist)

-Abnormal thoughts or loss of contact with reality (psychotic disorder)

Unknown frequency(the frequency of this side effect cannot be estimated from the available data):

  • Drug reaction with eosinophilia and systemic symptoms, also known as DRESS syndrome or drug hypersensitivity syndrome: generalized rash, elevated body temperature, elevated liver enzymes, blood abnormalities (eosinophilia), lymph node swelling, and involvement of other body organs.
  • Stevens-Johnson syndrome, SSJ. This severe skin eruption may appear as red macules with a target-like shape or as circular patches, often with blisters in the center, located on the trunk; skin peeling, ulcers in the mouth, throat, nose, genitals, and eyes, and may be preceded by fever and flu-like symptoms.

Stop using perampanel if any of these symptoms appear and consult your doctor or seek immediate medical attention. See also section 2.

Reporting of side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through theSistema Español de Farmacovigilancia de medicamentos de Uso Humano. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Fycompa Storage

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the box and on the blister pack. The expiration date is the last day of the month indicated.

No special storage conditions are required.

Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medication that you no longer need. This will help protect the environment.

6. Contents of the packaging and additional information

Composition of Fycompa

The active ingredient is perampanel. Each film-coated tablet contains 2mg, 4mg, 6mg, 8mg, 10mg, or 12mg of perampanel.

The other components are:

Core of the tablet (tablets of 2mg and 4mg):

Lactose monohydrate, low-substituted hydroxypropylcellulose, povidone, magnesium stearate (E470b)

Core of the tablet (tablets of 6mg, 8mg, 10mg, and 12mg)

Lactose monohydrate, low-substituted hydroxypropylcellulose, povidone, microcrystalline cellulose, magnesium stearate (E470b)

Film coating (tablets of 2mg, 4mg, 6mg, 8mg, 10mg, and 12mg)

Hydroxypropyl methylcellulose 2910, talc, Macrogol 8000, titanium dioxide (E171), colorants*

* The colorants are:

Tablet of 2mg: Iron oxide, Yellow (E172), Iron oxide, Red (E172)

Tablet of 4mg:Iron oxide, Red (E172)

Tablet of 6mg:Iron oxide, Red (E172)

Tablet of 8mg:Iron oxide, Red (E172), Iron oxide, Black (E172)

Tablet of 10mg: Iron oxide, Yellow (E172), FD&C Blue No. 2 Aluminum Lake Indigo Carmine (E132)

Tablet of 12mg:FD&C Blue No. 2 Aluminum Lake Indigo Carmine (E132)

Appearance of the product and contents of the package

All concentrations of Fycompa are film-coated, round, and biconvex tablets.

2mg: Orange in color, with the mark E275 on one face and 2 on the other face

4mg: Red in color, with the mark E277 on one face and 4 on the other face

6mg: Pink in color, with the mark E294 on one face and 6 on the other face

8mg: Purple in color, with the mark E295 on one face and 8 on the other face

10mg: Green in color, with the mark E296 on one face and 10 on the other face

12mg: Blue in color, with the mark E297 on one face and 12 on the other face

Fycompa is available in packages of:

Tablet of 2mg – package of 7, 28, and 98

Tablets of 4mg, 6mg, 8mg, 10mg, and 12mg – packages of 7, 28, 84, and 98

Only some package sizes may be commercially available.

Marketing Authorization Holder

Eisai GmbH

Edmund-Rumpler-Straße 3

60549 Frankfurt am Main

Germany

e-mail: [email protected]

Responsible for Manufacturing

Eisai GmbH

Edmund-Rumpler-Straße 3

60549 Frankfurt am Main

Germany

For more information about this medication, please contact the local representative of the marketing authorization holder:

België/Belgique/Belgien

Eisai SA/NV

Tél/Tel: +32 (0)800 158 58

Lietuva

Eisai GmbH

Tel: + 49 (0) 69 66 58 50

(Vokietija)

????????

Eisai GmbH

Te?.: + 49 (0) 69 66 58 50

(????????)

Luxembourg/Luxemburg

Eisai SA/NV

Tél/Tel: +32 (0)800 158 58

(Belgique/Belgien)

Ceská republika

Eisai GesmbH organizacni složka

Tel: + 420 242 485 839

Magyarország

Eisai GmbH

Tel.: + 49 (0) 69 6658 50

(Németország)

Danmark

Eisai AB

Tlf: + 46 (0) 8 501 01 600

(Sverige)

Malta

Cherubino LTD

Tel: +356 21343270

Deutschland

Eisa GmbH

Tel: + 49 (0) 69 66 58 50

Nederland

Eisai B.V.

Tel: + 31 (0) 900 575 3340

Eesti

Eisai GmbH

Tel: + 49 (0) 69 66 58 50

(Saksamaa)

Norge

Eisai AB

Tlf: + 46 (0) 8 501 01 600

(Sverige)

Ελλ?δα

Arriani Pharmaceutical S.A.

Τηλ: + 30 210 668 3000

Österreich

Eisai GesmbH

Tel: + 43 (0) 1 535 1980-0

España

Eisai Farmacéutica, S.A.

Tel: + (34) 91 455 94 55

Polska

Eisai GmbH

Tel: + 49 (0) 69 66 58 50

(Niemcy)

France

Eisai SAS

Tél: + (33) 147 67 00 05

Portugal

Eisai Farmacêtica, Unipessoal Lda

Tel: + 351 214 875 540

Hrvatska

Eisai GmbH

Tel: + 49 (0) 69 66 58 50

(Njemacka)

România

Eisai GmbH

Tel: + 49 (0) 69 66 58 50

(Germania)

Ireland

Eisai GmbH

Tel: + 49 (0) 69 66 58 50

(Germany)

Slovenija

Eisai GmbH

Tel: + 49 (0) 69 66 58 50

(Nemcija)

Ísland

Eisai AB

Sími: + 46 (0)8 501 01 600

(Svíþjóð)

Slovenská republika

Eisai GesmbH organizacni složka

Tel.: + 420 242 485 839

(Ceská republika)

Italia

Eisai S.r.l.

Tel: + 39 02 5181401

Suomi/Finland

Eisai AB

Puh/Tel: + 46 (0) 8 501 01 600

(Ruotsi)

Κ?προς

Arriani Pharmaceuticals S.A.

Τηλ: + 30 210 668 3000

(Ελλ?δα)

Sverige

Eisai AB

Tel: + 46 (0) 8 501 01 600

Latvija

Eisai GmbH

Tel: + 49 (0) 69 66 58 50

(Vacija)

United Kingdom (Northern Ireland)

Eisai GmbH

Tel: + 49 (0) 69 66 58 50

(Germany)

Last revision date of this leaflet:

The detailed information about this medication is available on the website of the European Medicines Agency: http://www.ema.europa.eu/.

Страна регистрации
Активное вещество
Требуется рецепт
Да
Производитель
Состав
Lactosa monohidrato (149,0 mg mg)
Информация носит справочный характер и не является медицинской рекомендацией. Перед приёмом любых препаратов проконсультируйтесь с врачом. Oladoctor не несёт ответственности за медицинские решения, принятые на основе этого контента.

Общайтесь с врачом онлайн

Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.

5.01 отзыв
Doctor

Anna Moret

Dermatology18 лет опыта

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for: • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis • Pediatric skin problems — from newborns to adolescents • Sexually transmitted infections (STIs) and dermatovenereology • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments • Skin allergies and hypersensitivity reactions • Mole checks, lesion evaluation, and skin cancer screening • Skincare advice and personalised cosmeceutical routines

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

Записаться на онлайн-консультацию
5.01 отзыв
Doctor

Alina Tsurkan

Family Medicine12 лет опыта

Dr. Alina Tsurkan is a licensed family medicine doctor based in Portugal. She provides personalised primary care for both adults and children, helping patients manage a wide range of everyday health concerns with professionalism and attention to detail.

Dr. Tsurkan diagnoses and treats common conditions such as: • Respiratory infections (cold, flu, bronchitis, pneumonia) • Eye conditions: conjunctivitis (infectious and allergic) • ENT problems (sinusitis, ear infections, tonsillitis) • Digestive issues including gastritis, acid reflux, and IBS • Urinary tract infections and other frequent infections • Chronic conditions such as high blood pressure, diabetes, and thyroid disorders • Headaches and migraines

In addition to symptom-based care, Dr. Tsurkan focuses on prevention and early detection. She offers regular health check-ups, follow-up care, and medical prescriptions tailored to each patient’s needs.

With a comprehensive and caring approach, Dr. Tsurkan supports patients at every stage of life — from acute illnesses to long-term health management.

Записаться на онлайн-консультацию
5.09 отзывов
Doctor

Andrei Popov

General Medicine6 лет опыта

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including: • Chronic pain lasting more than 3 months • Migraines and recurring headaches • Neck, back, lower back, and joint pain • Post-traumatic pain following injury or surgery • Nerve-related pain, fibromyalgia, and neuralgia In addition to pain management, Dr. Popov helps patients with: • Respiratory infections (colds, bronchitis, pneumonia) • High blood pressure and metabolic conditions such as diabetes • Preventive care and routine health check-ups

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

Записаться на онлайн-консультацию
5.01 отзыв
Doctor

Yevgen Yakovenko

General Surgery11 лет опыта

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain, with a diverse clinical background in general and pediatric surgery, internal medicine, and pain management. With a strong focus on both practice and research, he provides comprehensive medical consultations for adults and children, covering both surgical and therapeutic needs.

Dr. Yakovenko offers expert care in the following areas: • Diagnosis and treatment of acute and chronic pain • Pre- and postoperative care, including risk assessment and follow-up • Surgical conditions such as hernias, gallbladder disease, and appendicitis • Pediatric surgery consultations, including congenital conditions and minor procedures • Trauma care: fractures, soft tissue injuries, and wound management • Oncological surgery consultation and post-treatment care • Cardiovascular and respiratory conditions (internal medicine) • Orthopedic concerns and post-trauma rehabilitation • Radiological interpretation for surgical planning

In addition to his clinical work, Dr. Yakovenko actively participates in medical research and international collaboration. He is a member of the German Surgeons Association (BDC), affiliated with the General Practitioners Association of Las Palmas, and works with the German Consulate in the Canary Islands. He regularly attends international medical conferences and has authored scientific publications.

With over a decade of multidisciplinary experience, Dr. Yakovenko delivers precise, evidence-based care tailored to each patient’s needs.

Записаться на онлайн-консультацию
Смотреть всех врачей

Следите за новостями и экономьте на услугах

Советы врачей, обновления платформы и скидки для подписчиков.

Следите за нами в соцсетях